Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E W Kay

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Oncogene|July 11, 2007
Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transitionK M Sheehan, C Gulmann, G S Eichler, et al.
Irish Journal of Medical Science|May 1, 1994
Soft tissue and visceral sarcomas in Irish patients. Interim analysis of data obtained by the Dublin Soft Tissue Tumour PanelE F Gaffney, P A Dervan, M M McCabe, et al.
British Journal of Cancer|July 30, 2009
Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancerG A Doherty, S M Byrne, S C Austin, et al.
British Journal of Cancer|February 3, 2011
The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissueO Oladipo, S Conlon, A O'Grady, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 14, 2004
Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastasesK M Sheehan, R A Cahill, G McGreal, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 13, 2014
BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancerL Flanagan, A U Lindner, C de Chaumont, et al.
Cell Death & Disease|February 5, 2016
Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approachL Flanagan, M Meyer, J Fay, et al.
British Journal of Cancer|October 13, 2011
The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot studyJ A Gormley, S M Hegarty, A O'Grady, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 15, 2013
The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancerK I Abdul-Jalil, K M Sheehan, J Kehoe, et al.
Familial Cancer|May 29, 2013
Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicityM P Farrell, D J Hughes, M Drost, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Oncogene|July 11, 2007
Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transitionK M Sheehan, C Gulmann, G S Eichler, et al.
Irish Journal of Medical Science|May 1, 1994
Soft tissue and visceral sarcomas in Irish patients. Interim analysis of data obtained by the Dublin Soft Tissue Tumour PanelE F Gaffney, P A Dervan, M M McCabe, et al.
British Journal of Cancer|July 30, 2009
Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancerG A Doherty, S M Byrne, S C Austin, et al.
British Journal of Cancer|February 3, 2011
The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissueO Oladipo, S Conlon, A O'Grady, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 14, 2004
Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastasesK M Sheehan, R A Cahill, G McGreal, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 13, 2014
BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancerL Flanagan, A U Lindner, C de Chaumont, et al.
Cell Death & Disease|February 5, 2016
Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approachL Flanagan, M Meyer, J Fay, et al.
British Journal of Cancer|October 13, 2011
The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot studyJ A Gormley, S M Hegarty, A O'Grady, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 15, 2013
The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancerK I Abdul-Jalil, K M Sheehan, J Kehoe, et al.
Familial Cancer|May 29, 2013
Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicityM P Farrell, D J Hughes, M Drost, et al.
Pageof 8